Skip to main content
logo
ImmuPharma plc (AIM:IMM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
4.500
+0.500 (12.50%)
Jul 24, 2026, 4:45 PM GMT

ImmuPharma Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.12
Revenue Growth
------6.57%
Gross Profit
-----0.12
Operating Income
-2.53-2.53-2.27-3.06-3.03-5.16
Net Income
-1.81-1.81-2.48-2.92-3.81-8.17
Earnings Per Share
-0.00-0.00-0.01-0.01-0.01-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.351.350.240.210.671.65
Total Debt
----00
Net Cash (Debt)
1.351.350.240.210.671.65
Net Cash Growth
240.92%470.81%13.63%-68.78%-59.50%-68.42%
Net Cash Per Share
0.000.000.000.000.000.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.37-2.37-1.77-1.36-2.35-4.83
Capital Expenditures
-0-0-0--0.11-0.05
Free Cash Flow
-2.37-2.37-1.77-1.36-2.45-4.88
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----100.00%
Operating Margin
------4359.84%
Pretax Margin
------7554.47%
Profit Margin
------6906.55%
FCF Margin
------4126.83%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-48.0448.0448.0448.0448.04
PS Ratio
-----139.54